Integrated Patient Data™ & Medically Smart AI™

Powered Solutions for Rare Diseases, Oncology & Niche Sub-populations

We enable Real-Time Connected InsightsDynamic Patient JourneysReal World Data/EvidenceImproved OutcomesReduced Patient Drop-Offs & DiscontinuationsSuperior Product LaunchesData-driven Medical AffairsSmart Patient RegistriesHigher Quality Patient Care

We enable Medically Smart AI/MLReal World Data/EvidenceReal-Time Connected InsightsDynamic Patient JourneysImproved OutcomesRare Disease, Oncology, & Niche PopulationsReduced Patient Drop-Offs & Discontinuation

Clinakos is on a mission to transform human health through solutions built on the top of Integrated Patient Data™ and Medically Smart AI™. Our unique proprietary platform curates vast amounts of historical and real time, patient-level data including unstructured data from thousands of primary sources and links it to patient generated data including patient surveys, interviews, PROs, etc. to create comprehensive patient profiles.

Our Medically Smart AI™ engine has been designed by a passionate team of MDs, PharmDs, PhDs, data scientists & technologists, and combines deep medical experience with state-of-the-art technology expertise to enable novel solutions for our healthcare and life sciences clients. We have perfected our platform over a decade of R&D investments and have a successful track record of serving multiple healthcare and life science clients. Our current therapeutic focus is on rare diseases, oncology and niche sub-populations.

Our Approach

Clinakos’ unique approach leverages three core capabilities.

Integrated Patient Data™

Curating & Linking Patient Data from Primary Data Sources

Clinakos’ Integrated Patient Data™ is vastly superior to Syndicated and Tokenized Data

More than 10x data per patient
No data blocking
Linked across patient medical records, surveys, PROs and interviews
Longitudinal Retrospective & Prospective data
Higher Data Fidelity and Accuracy
Access to unstructured data including EMR notes and attachments
Fit For Use, Regulatory Use

Medically Smart AI™

Apply Medically Smart AI/ML to Illuminate Insights

Clinakos’ Medically Smart AI™ is fine-tuned for healthcare and life sciences

Proprietary AI/ML engine
Perfected over 10 years on large, robust RWD datasets
Natural Language Processing (NLP) parsing of unstructured documents
Identifies key insights that otherwise might be missed
Adaptable to a variety of use cases and customer needs
AI-Enabled data curation & insights
Enables unprecedented insights and transformative solutions

Transformative Solutions

Solving difficult and previously unsolvable problems in Life Sciences and Healthcare

Transformative solutions provide unprecedented insights & data generation opportunities

Dynamic insights vs static solutions provided by current approaches
Data fidelity, accuracy and depth enable novel solutions & new use cases
Solve a wide range of problems across healthcare and life sciences
Sample solutions include patient journeys, physician referral networks, patient drop-off analysis & more
Customizable to meet client’s open data questions

Rare Disease, Oncology & Niche Sub-Population Focus

Rare disease data is even harder to find with syndicated and tokenized data approaches. Clinakos’ solutions are ideally suited for life science companies focused on smaller populations, where product development and commercialization is extremely challenging. Clinakos unique partnerships give us access to 1300+ Disease Panels, 3000+ Advocacy Groups, Registries & Referral Partners and 750K HCPs focused on such diseases.

Rare Diseases

Currently, there are over 7,000 rare diseases affecting more than 30 million Americans. As of March 2023, 6,506 orphan drug designations have been granted by the US FDA of which 1,144 have led to orphan-designated approvals.

Oncology

In 2022, an estimated 1.9 million new cancer cases were diagnosed with 609,360 cancer deaths in the United States. Every oncology indication is different, each of which with their own intricacies.

Niche Sub-Populations

Many diseases have niche sub-populations with very specific characteristics – for example, different genotypes. Many new life sciences innovations target specific subpopulations

Our Customers

Empowering some of the largest Life Science companies and provider organizations.

What Our Customers Are Saying

❝ We’ve been knocking on physicians’ doors to learn some of this. You’ve been able to give us answers about our franchise we couldn’t find anywhere. ❞

Life Science Oncology Commercial Executive

❝ Data has a story, a story of patients and of pharma’s impact on patients. ❞

Clinakos Fortune 100 Life Science Client

❝ This is the first time I’ve been able to see 10 years of data across geographies in one place in a usable form. ❞

Clinakos Connected Insights Client at a Top 20 Pharmaceutical company

❝ This is a gift that will keep giving, because if you have a new question, you just have to go and ask it, you will come up with the answer. You have everything in your hand, you didn't lose anything by missing out on some question you did not write prospectively before you started asking these queries. So that's another important aspect that's going to be different here. And it's a game changer. ❞

Rare Disease Life Science Company CEO

Customer Segments

Clinakos empowers life science companies, providers and patients with our unique data and AI enabled insights. Our clients include established and specialized pharmaceutical companies seeking segmented and de-identified patient data essential for product development, launch and marketing, and physicians in diverse areas of practice to learn more about standard-of care and future treatments.

Pharmaceutical and Life Science Companies

New product innovation requires access to broadly based historical data, current research results, and projections to estimate levels of new product adoption. All phases of pharmaceutical product, marketing and evaluation are served by our seamless aggregation and presentation of critical data.

Commercial & Marketing

Medical Affairs & HEOR

Clinical Development

Other Use Cases

Healthcare Providers

As the front lines of treatment, providers are seeking information on emerging diseases, trends in patient populations, and forthcoming treatment modalities.

We’re supporting the field by bringing views of patient populations and treatments used across different healthcare systems providing the data to make treatment decisions for current and future patient groups.